BreezeBio Announces Scientific Advisory Board to Support Next Stage of Precision Genetic Medicine Pipeline Development SOUTH SAN FRANCISCO, Calif., May 26, 2026 — BreezeBio, Inc., formerly known as GenEdit, today announced the formation of its Scientific Advisory Board to support the company’s next stage of pipeline and platform development. The inaugural SAB brings together leaders […] The post BreezeBio Announces Scientific Advisory Board to Support Next Stage of Precision Genetic Medicine Pipeline Development first appeared on BreezeBio .